ROCKVILLE, Md.--([ BUSINESS WIRE ])--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that it will sponsor a conference call to discuss its financial results for the quarter ended March 31, 2012. These results are expected to be disclosed on Tuesday, April 24, 2012, after the capital markets close.
The conference call will be hosted by senior management and will be held on Tuesday, April 24, 2012 at 4:30 pm Eastern Time.
Investors may listen to the call by dialing 888-312-9844 or 719-325-2111, passcode 3946943. A replay of the conference call will be available within a few hours after the call ends. Investors may listen to the replay by dialing 888-203-1112 or 719-457-0820, confirmation code 3946943.
This conference call also will be webcast and can be accessed at [ www.hgsi.com ]. It is recommended that investors interested in listening to the live webcast log on before the start of the call to download any software required. Both the audio replay and the archive of the conference call webcast will remain available for several days.
ABOUT HUMAN GENOME SCIENCES
Human Genome Sciences exists to place new therapies into the hands of those battling serious disease.
For more information about HGS, please visit the Companyas web site at [ www.hgsi.com ]. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to [ clinicaltrialsinfo@hgsi.com ] or by calling HGS at (240) 314-4430.
HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc. Other trademarks referenced are the property of their respective owners.